Skip to main content

Advertisement

SpringerLink
Log in

IgA vasculitis with nephritis: update of pathogenesis with clinical implications

  • Review
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

IgA vasculitis with nephritis (IgAVN) shares many pathogenetic features with IgA nephropathy (IgAN). The purpose of this review is to describe our current understanding of the pathogenesis of pediatric IgAVN, particularly as it relates to the four-hit hypothesis for IgAN. These individual steps, i.e., hits, in the pathogenesis of IgAN are (1) elevated production of IgA1 glycoforms with some O-glycans deficient in galactose (galactose-deficient IgA1; Gd-IgA1), (2) generation of circulating IgG autoantibodies specific for Gd-IgA1, (3) formation of pathogenic circulating Gd-IgA1–containing immune complexes, and (4) kidney deposition of the Gd-IgA1-IgG immune complexes from the circulation and induction of glomerular injury. Evidence supporting the four-hit hypothesis in the pathogenesis of pediatric IgAVN is detailed. The genetics, pediatric outcomes, and kidney histopathologic features and the impact of these findings on future treatment and potential biomarkers are discussed. In summary, the evidence points to the critical roles of Gd-IgA1-IgG immune complexes and complement activation in the pathogenesis of IgAVN. Future studies are needed to characterize the features of the immune and autoimmune responses that enable progression of IgA vasculitis to IgAVN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Heberden W (1806) Commentaries on the history and cure of diseases. London

  2. Schönlein JL (1837) Allgemeine und Spezielle Pathologie und Therapie

  3. Henoch E (1874) Über eine eigentümliche Form von Purpura. Berl Klin Wochenschr 11:641–643

  4. Henoch E, in Herschward, A (ed): Vorlesungen uber kinderkranheiten, vol 10, Berlin, Aufl, p 839 (1899) Vorlesungen uber kinderkranheiten. In: Herschward A (ed) Vorlesungen uber kinderkranheiten, Berlin, pp Aufl, p 839

  5. Davin JC, Coppo R (2014) Henoch-Schönlein purpura nephritis in children. Nat Rev Nephrol 10:563–573

    CAS  PubMed  Google Scholar 

  6. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65:1–11

    CAS  Google Scholar 

  7. Berger J (1969) IgA glomerular deposits in renal disease. Transplant Proc 1:939–944

    CAS  PubMed  Google Scholar 

  8. Urizar RE, Michael A, Sisson S, Vernier RL (1968) Anaphylactoid purpura. II. Immunofluorescent and electron microscopic studies of the glomerular lesions. Lab Invest 19:437–450

    CAS  PubMed  Google Scholar 

  9. Evans DJ, Williams DG, Peters DK, Sissons JG, Boulton-Jones JM, Ogg CS, Cameron JS, Hoffbrand BI (1973) Glomerular deposition of properdin in Henoch-Schönlein syndrome and idiopathic focal nephritis. Br Med J 3:326–328

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Conley ME, Cooper MD, Michael AF (1980) Selective deposition of immunoglobulin A1 in immunoglobulin A nephropathy, anaphylactoid purpura nephritis, and systemic lupus erythematosus. J Clin Invest 66:1432–1436

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Wyatt RJ, Julian BA (2013) IgA nephropathy. N Engl J Med 368:2402–2414

    CAS  PubMed  Google Scholar 

  12. Selewski DT, Ambruzs JM, Appel GB, Bomback AS, Matar RB, Cai Y, Cattran DC, Chishti AS, D'Agati VD, D'Alessandri-Silva CJ, Gbadegesin RA, Hogan JJ, Iragorri S, Jennette JC, Julian BA, Khalid M, Lafayette RA, Liapis H, Lugani F, Mansfield SA, Mason S, Nachman PH, Nast CC, Nester CM, Noone DG, Novak J, O'Shaughnessy MM, Reich HN, Rheault MN, Rizk DV, Saha MK, Sanghani NS, Sperati CJ, Sreedharan R, Srivastava T, Swiatecka-Urban A, Twombley K, Vasylyeva TL, Weaver DJ, Yin H, Zee J, Falk RJ, Gharavi AG, Gillespie BW, Gipson DS, Greenbaum LA, Holzman LB, Kretzler M, Robinson BM, Smoyer WE, Flessner M, Guay-Woodford LM, Kiryluk K (2018) Clinical characteristics and treatment patterns of children and adults with IgA nephropathy or IgA vasculitis: findings from the CureGN study. Kidney Int Rep 3:1373–1384

    PubMed  PubMed Central  Google Scholar 

  13. Levy M, Broyer M, Arsan A, Levy-Bentolila D, Habib R (1976) Anaphylactoid purpura nephritis in childhood: natural history and immunopathology. Adv Nephrol Necker Hosp 6:183–228

    CAS  PubMed  Google Scholar 

  14. Nakamoto Y, Asano Y, Dohi K, Fujioka M, Iida H, Kida H, Kibe Y, Hattori N, Takeuchi J (1978) Primary IgA glomerulonephritis and Schönlein-Henoch purpura nephritis: clinicopathological and immunohistological characteristics. Q J Med 47:495–516

    CAS  PubMed  Google Scholar 

  15. Kamei K, Ogura M, Sato M, Ito S, Ishikura K (2016) Evolution of IgA nephropathy into anaphylactoid purpura in six cases--further evidence that IgA nephropathy and Henoch-Schonlein purpura nephritis share common pathogenesis. Pediatr Nephrol 31:779–785

    PubMed  Google Scholar 

  16. Meadow SR, Scott DG (1985) Berger disease: Henoch-Schönlein syndrome without the rash. J Pediat 106:27–32

    CAS  PubMed  Google Scholar 

  17. Julian BA, Quiggins PA, Thompson JS, Woodford SY, Gleason K, Wyatt RJ (1985) Familial IgA nephropathy. Evidence of an inherited mechanism of disease. N Engl J Med 312:202–208

    CAS  PubMed  Google Scholar 

  18. Levy M (1989) Familial cases of Berger’s disease and anaphylactoid purpura: more frequent than previously thought. Am J Med 87:246–248

    CAS  PubMed  Google Scholar 

  19. Lavigne KA, Woodford SY, Barker CV, Julian BA, Novak J, Moldoveanu Z, Gharavi AG, Wyatt RJ (2010) Familial IgA nephropathy in southeastern Kentucky. Clin Nephrol 73:115–121

    CAS  PubMed  Google Scholar 

  20. Suzuki H, Kiryluk K, Novak J, Moldoveanu Z, Herr AB, Renfrow MB, Wyatt RJ, Scolari F, Mestecky J, Gharavi AG, Julian BA (2011) The pathophysiology of IgA nephropathy. J Am Soc Nephrol 22:1795–1803

    CAS  PubMed  PubMed Central  Google Scholar 

  21. Lau KK, Suzuki H, Novak J, Wyatt RJ (2010) Pathogenesis of Henoch-Schönlein purpura nephritis. Pediatr Nephrol 25:19–26

    PubMed  PubMed Central  Google Scholar 

  22. Waldo FB (1988) Is Henoch-Schönlein purpura the systemic form of IgA nephropathy? Am J Kidney Dis 12:373–377

    CAS  PubMed  Google Scholar 

  23. Davin JC, Ten Berge IJ, Weening JJ (2001) What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? Kidney Int 59:823–834

    CAS  PubMed  Google Scholar 

  24. Novak J, Julian BA, Mestecky J, Renfrow MB (2012) Glycosylation of IgA1 and pathogenesis of IgA nephropathy. Semin Immunopathol 34:365–382

    CAS  PubMed  Google Scholar 

  25. Moldoveanu Z, Wyatt RJ, Lee J, Tomana M, Julian BA, Mestecky J, Huang W-Q, Anreddy S, Hall S, Hastings MC, Lau KK, Cook WJ, Novak J (2007) Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. Kidney Int 71:1148–1154

    CAS  PubMed  Google Scholar 

  26. Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J (1999) Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J Clin Invest 104:73–81

    CAS  PubMed  PubMed Central  Google Scholar 

  27. Suzuki H, Fan R, Zhang Z, Brown R, Hall S, Julian BA, Chatham WW, Suzuki Y, Wyatt RJ, Moldoveanu Z, Lee JY, Robinson J, Tomana M, Tomino Y, Mestecky J, Novak J (2009) Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. J Clin Invest 119:1668–1677

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Huang ZQ, Raska M, Stewart TJ, Reily C, King RG, Crossman DK, Crowley MR, Hargett A, Zhang Z, Suzuki H, Hall S, Wyatt RJ, Julian BA, Renfrow MB, Gharavi AG, Novak J (2016) Somatic mutations modulate autoantibodies against galactose-deficient IgA1 in IgA nephropathy. J Am Soc Nephrol 27:3278–3284

    PubMed  PubMed Central  Google Scholar 

  29. Rizk DV, Saha MK, Hall S, Novak L, Brown R, Huang ZQ, Julian BA, Novak J (2019) Glomerular immunodeposits of patients with IgA nephropathy are enriched for IgG autoantibodies specific for galactose-deficient IgA1. J Am Soc Nephrol 30:2017–2026

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Novak J, Tomana M, Matousovic K, Brown R, Hall S, Novak L, Julian BA, Wyatt RJ, Mestecky J (2005) IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int 67:504–513

    CAS  PubMed  Google Scholar 

  31. Novak J, Raskova Kafkova L, Suzuki H, Tomana M, Matousovic K, Brown R, Hall S, Sanders JT, Eison TM, Moldoveanu Z, Novak L, Novak Z, Mayne R, Julian BA, Mestecky J, Wyatt RJ (2011) IgA1 immune complexes from pediatric patients with IgA nephropathy activate cultured mesangial cells. Nephrol Dial Transplant 26:3451–3457

    CAS  PubMed  PubMed Central  Google Scholar 

  32. Moura IC, Arcos-Fajardo M, Sadaka C, Leroy V, Benhamou M, Novak J, Vrtovsnik F, Haddad E, Chintalacharuvu KR, Monteiro RC (2004) Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J Am Soc Nephrol 15:622–634

    CAS  PubMed  Google Scholar 

  33. Maillard N, Wyatt RJ, Julian BA, Kiryluk K, Gharavi A, Fremeaux-Bacchi V, Novak J (2015) Current understanding of the role of complement in IgA nephropathy. J Am Soc Nephrol 26:1503–1512

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Rizk DV, Maillard N, Julian BA, Knoppova B, Green TJ, Novak J, Wyatt RJ (2019) The emerging role of complement proteins as a target for therapy of IgA nephropathy. Invited review. Front Immunol 10:504

    CAS  PubMed  PubMed Central  Google Scholar 

  35. Lai KN, Leung JC, Chan LY, Saleem MA, Mathieson PW, Lai FM, Tang SC (2008) Activation of podocytes by mesangial-derived TNF-α: glomerulo-podocytic communication in IgA nephropathy. Am J Physiol Renal Physiol 294:F945–F955

    CAS  PubMed  Google Scholar 

  36. Lai KN, Tang SC, Schena FP, Novak J, Tomino Y, Fogo AB, Glassock RJ (2016) IgA nephropathy. Nat Rev Dis Primers 2:16001

    PubMed  Google Scholar 

  37. Saulsbury FT (1997) Alterations in the O-linked glycosylation of IgA1 in children with Henoch-Schönlein purpura. J Rheumatol 24:2246–2249

    CAS  PubMed  Google Scholar 

  38. Allen AC, Willis FR, Beattie TJ, Feehally J (1998) Abnormal IgA glycosylation in Henoch-Schönlein purpura restricted to patients with clinical nephritis. Nephrol Dial Transplant 13:930–934

  39. Nakazawa S, Imamura R, Kawamura M, Kato T, Abe T, Iwatani H, Yamanaka K, Uemura M, Kishikawa H, Nishimura K, Tajiri M, Wada Y, Nonomura N (2019) Evaluation of IgA1 O-glycosylation in Henoch-Schönlein purpura nephritis using mass spectrometry. Transplant Proc 51:1481–1487

    CAS  PubMed  Google Scholar 

  40. Lau KK, Wyatt RJ, Moldoveanu Z, Tomana M, Julian BJ, Hogg RJ, Lee JY, Huang W-Q, Mestecky J, Novak J (2007) Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schoenlein purpura. Pediatr Nephrol 22:2067–2072

    PubMed  Google Scholar 

  41. Pillebout E, Jamin A, Ayari H, Housset P, Pierre M, Sauvaget V, Viglietti D, Deschenes G, Monteiro RC, Berthelot L (2017) Biomarkers of IgA vasculitis nephritis in children. PLoS One 12:e0188718

    PubMed  PubMed Central  Google Scholar 

  42. Mizerska-Wasiak M, Gajewski L, Cichon-Kawa K, Maldyk J, Dziedzic-Jankowska K, Leszczynska B, Rybi-Szuminska A, Wasilewska A, Pukajlo-Marczyk A, Zwolinska D, Bienias B, Sikora P, Szczepanska M, Stelmaszczyk-Emmel A, Gorska E, Panczyk-Tomaszewska M (2018) Serum GDIgA1 levels in children with IgA nephropathy and Henoch-Schönlein nephritis. Cent Eur J Immunol 43:162–167

    CAS  PubMed  PubMed Central  Google Scholar 

  43. Zhang X, Xie X, Shi S, Liu L, Lv J, Zhang H (2020) Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis. Nephrol Dial Transplant 35:2117–2123. https://doi.org/10.1093/ndt/gfz151

    Article  CAS  PubMed  Google Scholar 

  44. Suzuki H, Moldoveanu Z, Julian BA, Wyatt RJ, Novak J (2019) Autoantibodies specific for galactose-deficient IgA1 in IgA vasculitis with nephritis. Kidney Int Rep 4:1717–1724

    PubMed  PubMed Central  Google Scholar 

  45. Gharavi AG, Moldoveanu Z, Wyatt RJ, Barker CV, Woodford SY, Lifton RP, Mestecky J, Novak J, Julian BA (2008) Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy. J Am Soc Nephrol 19:1008–1014

    PubMed  PubMed Central  Google Scholar 

  46. Kiryluk K, Li Y, Moldoveanu Z, Suzuki H, Reily C, Hou P, Xie J, Mladkova N, Prakash S, Fischman C, Shapiro S, LeDesma RA, Bradbury D, Ionita-Laza I, Eitner F, Rauen T, Maillard N, Berthoux F, Floege J, Chen N, Zhang H, Scolari F, Wyatt RJ, Julian BA, Gharavi AG, Novak J (2017) GWAS for serum galactose-deficient IgA1 implicates critical genes of the O-glycosylation pathway. PLoS Genet 13:e1006609

    PubMed  PubMed Central  Google Scholar 

  47. Kiryluk K, Moldoveanu Z, Sanders JT, Eison TM, Suzuki H, Julian BA, Novak J, Gharavi AG, Wyatt RJ (2011) Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis. Kidney Int 80:79–87

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Yamada K, Kobayashi N, Ikeda T, Suzuki Y, Tsuge T, Horikoshi S, Emancipator SN, Tomino Y (2010) Down-regulation of core 1 β1,3-galactosyltransferase and Cosmc by Th2 cytokine alters O-glycosylation of IgA1. Nephrol Dial Transplant 25:3890–3897

    CAS  PubMed  PubMed Central  Google Scholar 

  49. Yamada K, Huang Z-Q, Raska M, Reily CR, Aderson J, Suzuki H, Ueda H, Moldoveanu Z, Kiryluk K, Suzuki Y, Wyatt RJ, Tomino Y, Gharavi AG, Weinmann A, Julian BA, Willey CD, Novak J (2017) Inhibition of STAT3 signaling reduces IgA1 autoantigen production in IgA nephropathy. Kidney Int Rep 2:1194–1207

    PubMed  PubMed Central  Google Scholar 

  50. Yamada K, Huang ZQ, Raska M, Reily C, Anderson JC, Suzuki H, Kiryluk K, Gharavi AG, Julian BA, Willey CD, Novak J (2020) Leukemia inhibitory factor signaling enhances production of galactose-deficient IgA1 in IgA nephropathy. Kidney Dis 6:168–180

    Google Scholar 

  51. Reily C, Ueda H, Huang ZQ, Mestecky J, Julian BA, Willey CD, Novak J (2014) Cellular signaling and production of galactose-deficient IgA1 in IgA nephropathy, an autoimmune disease. J Immunol Res 2014:197548

    PubMed  PubMed Central  Google Scholar 

  52. Knoppova B, Reily C, Maillard N, Rizk DV, Moldoveanu Z, Mestecky J, Raska M, Renfrow MB, Julian BA, Novak J (2016) The origin and activities of IgA1-containing immune complexes in IgA nephropathy. Front Immunol 7:117

    PubMed  PubMed Central  Google Scholar 

  53. Novak J, Barratt J, Julian BA, Renfrow MB (2018) Aberrant glycosylation of the IgA1 molecule in IgA nephropathy. Semin Nephrol 38:461–476

    CAS  PubMed  PubMed Central  Google Scholar 

  54. Placzek WJ, Yanagawa H, Makita Y, Renfrow MB, Julian BA, Rizk DV, Suzuki Y, Novak J, Suzuki H (2018) Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy. PLoS One 13:e0190967

    PubMed  PubMed Central  Google Scholar 

  55. Levinsky RJ, Barratt TM (1979) IgA immune complexes in Henoch-Schönlein purpura. Lancet 2:1100–1103

    CAS  PubMed  Google Scholar 

  56. Kauffmann RH, Van Es LA, Daha MR (1981) The specific detection of IgA in immune complexes. J Immunol Methods 40:117–129

    CAS  PubMed  Google Scholar 

  57. Coppo R, Basolo B, Martina G, Rollino C, De Marchi M, Giacchino F, Mazzucco G, Messina M, Piccoli G (1982) Circulating immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schönlein nephritis. Correlation with clinical and histologic signs of activity. Clin Nephrol 18:230–239

    CAS  PubMed  Google Scholar 

  58. Tanaka H (1984) Circulating immune complex and complement in children with various glomerulonephritides, especially the cases with IgA nephropathy or Henoch-Schönlein purpura nephritis. Nihon Jinzo Gakkai Shi 26:1131–1142

    CAS  PubMed  Google Scholar 

  59. Westedt ML, Daha MR, de Vries E, Valentijn RM, Cats A (1985) IgA containing immune complexes in rheumatoid vasculitis and in active rheumatoid disease. J Rheumatol 12:449–455

    CAS  PubMed  Google Scholar 

  60. Blanco Quiros A, Blanco C, Alvarez J, Solis P, Conde F, Gomez S (1994) Anti-immunoglobulin antibodies in children with Schönlein-Henoch syndrome. Absence of serum anti-IgA antibodies. Eur J Pediatr 153:103–106

    CAS  PubMed  Google Scholar 

  61. Saulsbury FT (1987) The role of IgA1 rheumatoid factor in the formation of IgA-containing immune complexes in Henoch-Schönlein purpura. J Clin Lab Immunol 23:123–127

    CAS  PubMed  Google Scholar 

  62. Hilhorst M, van Paassen P, van Breda Vriesman P, Cohen Tervaert JW (2011) Immune complexes in acute adult-onset Henoch-Schönlein nephritis. Nephrol Dial Transplant 26:3960–3967

    CAS  PubMed  Google Scholar 

  63. Novak J, Moldoveanu Z, Renfrow MB, Yanagihara T, Suzuki H, Raska M, Hall S, Brown R, Huang WQ, Goepfert A, Kilian M, Poulsen K, Tomana M, Wyatt RJ, Julian BA, Mestecky J (2007) IgA nephropathy and Henoch-Schoenlein purpura nephritis: aberrant glycosylation of IgA1, formation of IgA1-containing immune complexes, and activation of mesangial cells. Contrib Nephrol 157:134–138

    CAS  PubMed  Google Scholar 

  64. Allen AC, Bailey EM, Brenchley PEC, Buck KS, Barratt J, Feehally J (2001) Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: observations in three patients. Kidney Int 60:969–973

    CAS  PubMed  Google Scholar 

  65. Hiki Y, Odani H, Takahashi M, Yasuda Y, Nishimoto A, Iwase H, Shinzato T, Kobayashi Y, Maeda K (2001) Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int 59:1077–1085

    CAS  PubMed  Google Scholar 

  66. Suzuki H, Yasutake J, Makita Y, Tanbo Y, Yamasaki K, Sofue T, Kano T, Suzuki Y (2018) IgA nephropathy and IgA vasculitis with nephritis have a shared feature involving galactose-deficient IgA1-oriented pathogenesis. Kidney Int Rep 93:700–705

    CAS  Google Scholar 

  67. Zhao L, Peng L, Yang D, Chen S, Lan Z, Zhu X, Yuan S, Chen G, Liu Y, Liu H (2020) Immunostaining of galactose-deficient IgA1 by KM55 is not specific for immunoglobulin A nephropathy. Clin Immunol 217:108483

    CAS  PubMed  Google Scholar 

  68. Endo M, Ohi H, Ohsawa I, Fujita T, Matsushita M (2000) Complement activation through the lectin pathway in patients with Henoch-Schönlein purpura nephritis. Am J Kidney Dis 35:401–407

    CAS  PubMed  Google Scholar 

  69. Hisano S, Matsushita M, Fujita T, Iwasaki H (2005) Activation of the lectin complement pathway in Henoch-Schönlein purpura nephritis. Am J Kidney Dis 45:295–302

    CAS  PubMed  Google Scholar 

  70. Dumont C, Merouani A, Ducruet T, Benoit G, Clermont MJ, Lapeyraque AL, Phan V, Patey N (2020) Clinical relevance of membrane attack complex deposition in children with IgA nephropathy and Henoch-Schönlein purpura. Pediatr Nephrol 35:843–850

    PubMed  Google Scholar 

  71. Jia M, Zhu L, Zhai YL, Chen P, Xu BY, Guo WY, Shi SF, Liu LJ, Lv JC, Zhang H (2020) Variation in complement factor H affects complement activation in immunoglobulin A vasculitis with nephritis. Nephrology 25:40–47

    CAS  PubMed  Google Scholar 

  72. Selvaskandan H, Kay Cheung C, Dormer J, Wimbury D, Martinez M, Xu G, Barratt J (2020) Inhibition of the lectin pathway of the complement system as a novel approach in the management of IgA vasculitis-associated nephritis. Nephron 144:453–458. https://doi.org/10.1159/000508841

    Article  CAS  PubMed  Google Scholar 

  73. Besbas N, Saatci U, Ruacan S, Ozen S, Sungur A, Bakkaloglu A, Elnahas AM (1997) The role of cytokines in Henoch Schönlein purpura. Scand J Rheumatol 26:456–460

    CAS  PubMed  Google Scholar 

  74. Ha TS (2005) The role of tumor necrosis factor-α in Henoch-Schönlein purpura. Pediatr Nephrol 20:149–153

    PubMed  Google Scholar 

  75. Del Vecchio GC, Penza R, Altomare M, Piacente L, Aceto G, Lassandro G, De Mattia D, Giordano P (2008) Cytokine pattern and endothelium damage markers in Henoch-Schönlein purpura. Immunopharmacol Immunotoxicol 30:623–629

    PubMed  Google Scholar 

  76. Su Z, Lv X, Liu Y, Zhang J, Guan J, Gai Z (2016) Circulating midkine in children with Henoch-Schönlein purpura: clinical implications. Int Immunopharmacol 39:246–250

    CAS  PubMed  Google Scholar 

  77. Jaszczura M, Mizgala-Izworska E, Swietochowska E, Machura E (2019) Serum levels of selected cytokines [interleukin (IL)-17A, IL-18, IL-23] and chemokines (RANTES, IP10) in the acute phase of immunoglobulin A vasculitis in children. Rheumatol Int 39:1945–1953

    CAS  PubMed  PubMed Central  Google Scholar 

  78. Lin CY, Yang YH, Lee CC, Huang CL, Wang LC, Chiang BL (2006) Thrombopoietin and interleukin-6 levels in Henoch-Schönlein purpura. J Microbiol Immunol Infect 39:476–482

    CAS  PubMed  Google Scholar 

  79. Jen HY, Chuang YH, Lin SC, Chiang BL, Yang YH (2011) Increased serum interleukin-17 and peripheral Th17 cells in children with acute Henoch-Schönlein purpura. Pediatr Allergy Immunol 22:862–868

    PubMed  Google Scholar 

  80. Galla JH, Kohaut EC, Alexander R, Mestecky J (1984) Racial difference in the prevalence of IgA-associated nephropathies. Lancet 2:522

    CAS  PubMed  Google Scholar 

  81. Gardner-Medwin JM, Dolezalova P, Cummins C, Southwood TR (2002) Incidence of Henoch-Schönlein purpura, Kawasaki disease, and rare vasculitides in children of different ethnic origins. Lancet 360:1197–1202

    PubMed  Google Scholar 

  82. Lopez-Mejias R, Castaneda S, Genre F, Remuzgo-Martinez S, Carmona FD, Llorca J, Blanco R, Martin J, Gonzalez-Gay MA (2018) Genetics of immunoglobulin-A vasculitis (Henoch-Schönlein purpura): an updated review. Autoimmun Rev 17:301–315

    CAS  PubMed  Google Scholar 

  83. Feehally J, Farrall M, Boland A, Gale DP, Gut I, Heath S, Kumar A, Peden JF, Maxwell PH, Morris DL, Padmanabhan S, Vyse TJ, Zawadzka A, Rees AJ, Lathrop M, Ratcliffe PJ (2010) HLA has strongest association with IgA nephropathy in genome-wide analysis. J Am Soc Nephrol 21:1791–1797

    CAS  PubMed  PubMed Central  Google Scholar 

  84. Gharavi AG, Kiryluk K, Choi M, Li Y, Hou P, Xie J, Sanna-Cherchi S, Men CJ, Julian BA, Wyatt RJ, Novak J, He JC, Wang H, Lv J, Zhu L, Wang W, Wang Z, Yasuno K, Gunel M, Mane S, Umlauf S, Tikhonova I, Beerman I, Savoldi S, Magistroni R, Ghiggeri GM, Bodria M, Lugani F, Ravani P, Ponticelli C, Allegri L, Boscutti G, Frasca G, Amore A, Peruzzi L, Coppo R, Izzi C, Viola BF, Prati E, Salvadori M, Mignani R, Gesualdo L, Bertinetto F, Mesiano P, Amoroso A, Scolari F, Chen N, Zhang H, Lifton RP (2011) Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet 43:321–327

    CAS  PubMed  PubMed Central  Google Scholar 

  85. Yu XQ, Li M, Zhang H, Low HQ, Wei X, Wang JQ, Sun LD, Sim KS, Li Y, Foo JN, Wang W, Li ZJ, Yin XY, Tang XQ, Fan L, Chen J, Li RS, Wan JX, Liu ZS, Lou TQ, Zhu L, Huang XJ, Zhang XJ, Liu ZH, Liu JJ (2011) A genome-wide association study in Han Chinese identifies multiple susceptibility loci for IgA nephropathy. Nat Genet 44:178–182

    PubMed  Google Scholar 

  86. Kiryluk K, Li Y, Sanna-Cherchi S, Rohanizadegan M, Suzuki H, Eitner F, Snyder HJ, Choi M, Hou P, Scolari F, Izzi C, Gigante M, Gesualdo L, Savoldi S, Amoroso A, Cusi D, Zamboli P, Julian BA, Novak J, Wyatt RJ, Mucha K, Perola M, Kristiansson K, Viktorin A, Magnusson PK, Thorleifsson G, Thorsteinsdottir U, Stefansson K, Boland A, Metzger M, Thibaudin L, Wanner C, Jager KJ, Goto S, Maixnerova D, Karnib HH, Nagy J, Panzer U, Xie J, Chen N, Tesar V, Narita I, Berthoux F, Floege J, Stengel B, Zhang H, Lifton RP, Gharavi AG (2012) Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet 8:e1002765

    CAS  PubMed  PubMed Central  Google Scholar 

  87. Kiryluk K, Li Y, Scolari F, Sanna-Cherchi S, Choi M, Verbitsky M, Fasel D, Lata S, Prakash S, Shapiro S, Fischman C, Snyder HJ, Appel G, Izzi C, Viola BF, Dallera N, Del Vecchio L, Barlassina C, Salvi E, Bertinetto FE, Amoroso A, Savoldi S, Rocchietti M, Amore A, Peruzzi L, Coppo R, Salvadori M, Ravani P, Magistroni R, Ghiggeri GM, Caridi G, Bodria M, Lugani F, Allegri L, Delsante M, Maiorana M, Magnano A, Frasca G, Boer E, Boscutti G, Ponticelli C, Mignani R, Marcantoni C, Di Landro D, Santoro D, Pani A, Polci R, Feriozzi S, Chicca S, Galliani M, Gigante M, Gesualdo L, Zamboli P, Battaglia GG, Garozzo M, Maixnerova D, Tesar V, Eitner F, Rauen T, Floege J, Kovacs T, Nagy J, Mucha K, Paczek L, Zaniew M, Mizerska-Wasiak M, Roszkowska-Blaim M, Pawlaczyk K, Gale D, Barratt J, Thibaudin L, Berthoux F, Canaud G, Boland A, Metzger M, Panzer U, Suzuki H, Goto S, Narita I, Caliskan Y, Xie J, Hou P, Chen N, Zhang H, Wyatt RJ, Novak J, Julian BA, Feehally J, Stengel B, Cusi D, Lifton RP, Gharavi AG (2014) Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens. Nat Genet 46:1187–1196

    CAS  PubMed  PubMed Central  Google Scholar 

  88. Li M, Foo JN, Wang JQ, Low HQ, Tang XQ, Toh KY, Yin PR, Khor CC, Goh YF, Irwan ID, Xu RC, Andiappan AK, Bei JX, Rotzschke O, Chen MH, Cheng CY, Sun LD, Jiang GR, Wong TY, Lin HL, Aung T, Liao YH, Saw SM, Ye K, Ebstein RP, Chen QK, Shi W, Chew SH, Chen J, Zhang FR, Li SP, Xu G, Tai ES, Wang L, Chen N, Zhang XJ, Zeng YX, Zhang H, Liu ZH, Yu XQ, Liu JJ (2015) Identification of new susceptibility loci for IgA nephropathy in Han Chinese. Nat Commun 6:7270

    CAS  PubMed  Google Scholar 

  89. Lopez-Mejias R, Carmona FD, Castaneda S, Genre F, Remuzgo-Martinez S, Sevilla-Perez B, Ortego-Centeno N, Llorca J, Ubilla B, Mijares V, Pina T, Miranda-Filloy JA, Navas Parejo A, de Argila D, Aragues M, Rubio E, Luque ML, Blanco-Madrigal JM, Galindez-Aguirregoikoa E, Jayne D, Blanco R, Martin J, Gonzalez-Gay MA (2017) A genome-wide association study suggests the HLA class II region as the major susceptibility locus for IgA vasculitis. Sci Rep 7:5088

    PubMed  PubMed Central  Google Scholar 

  90. Meadow SR, Glasgow EF, White RH, Moncrieff MW, Cameron JS, Ogg CS (1972) Schönlein-Henoch nephritis. Q J Med 41:241–258

    CAS  PubMed  Google Scholar 

  91. Counahan R, Winterborn MH, White RH, Heaton JM, Meadow SR, Bluett NH, Swetschin H, Cameron JS, Chantler C (1977) Prognosis of Henoch-Schönlein nephritis in children. Br Med J 2:11–14

    CAS  PubMed  PubMed Central  Google Scholar 

  92. Yoshikawa N, White RH, Cameron AH (1981) Prognostic significance of the glomerular changes in Henoch-Schoenlein nephritis. Clin Nephrol 16:223–229

    CAS  PubMed  Google Scholar 

  93. Yoshikawa N, Ito H, Yoshiya K, Nakahara C, Yoshiara S, Hasegawa O, Matsuyama S, Matsuo T (1987) Henoch-Schoenlein nephritis and IgA nephropathy in children: a comparison of clinical course. Clin Nephrol 27:233–237

    CAS  PubMed  Google Scholar 

  94. Goldstein AR, White RH, Akuse R, Chantler C (1992) Long-term follow-up of childhood Henoch-Schönlein nephritis. Lancet 339:280–282

    CAS  PubMed  Google Scholar 

  95. Ronkainen J, Nuutinen M, Koskimies O (2002) The adult kidney 24 years after childhood Henoch-Schönlein purpura: a retrospective cohort study. Lancet 360:666–670

    PubMed  Google Scholar 

  96. Foster BJ, Bernard C, Drummond KN, Sharma AK (2000) Effective therapy for severe Henoch-Schönlein purpura nephritis with prednisone and azathioprine: a clinical and histopathologic study. J Pediatr 136:370–375

    CAS  PubMed  Google Scholar 

  97. Kawasaki Y, Suzuki J, Sakai N, Nemoto K, Nozawa R, Suzuki S, Suzuki H (2003) Clinical and pathological features of children with Henoch-Schoenlein purpura nephritis: risk factors associated with poor prognosis. Clin Nephrol 60:153–160

    CAS  PubMed  Google Scholar 

  98. Shin JI, Park JM, Shin YH, Kim JH, Lee JS, Kim PK, Jeong HJ (2005) Can azathioprine and steroids alter the progression of severe Henoch-Schönlein nephritis in children? Pediatr Nephrol 20:1087–1092

    PubMed  Google Scholar 

  99. Mir S, Yavascan O, Mutlubas F, Yeniay B, Sonmez F (2007) Clinical outcome in children with Henoch-Schönlein nephritis. Pediatr Nephrol 22:64–70

    PubMed  Google Scholar 

  100. Shenoy M, Bradbury MG, Lewis MA, Webb NJ (2007) Outcome of Henoch-Schönlein purpura nephritis treated with long-term immunosuppression. Pediatr Nephrol 22:1717–1722

    PubMed  Google Scholar 

  101. Lucas Garcia J, Alvarez Blanco O, Sanahuja Ibanez MJ, Ortega Lopez PJ, Zamora Martin I (2008) Outcome of Henoch-Schönlein nephropathy in pediatric patients. Prognostic factors. Nefrologia 28:627–632

    CAS  PubMed  Google Scholar 

  102. Fu H, Mao J, Huang J, Gu W, Lu Z (2016) Higher pathological grading is associated with unfavorable outcome of Henoch-Schonlein purpura nephritis in children. Int J Clin Exp Pathol 9:4633–4640

    CAS  Google Scholar 

  103. Feng D, Huang WY, Hao S, Niu XL, Wang P, Wu Y, Zhu GH (2017) A single-center analysis of Henoch-Schonlein purpura nephritis with nephrotic proteinuria in children. Pediatr Rheumatol 15:15

    Google Scholar 

  104. Koskela M, Ylinen E, Ukonmaanaho EM, Autio-Harmainen H, Heikkila P, Lohi J, Jauhola O, Ronkainen J, Jahnukainen T, Nuutinen M (2017) The ISKDC classification and a new semiquantitative classification for predicting outcomes of Henoch-Schönlein purpura nephritis. Pediatr Nephrol 32:1201–1209

    PubMed  Google Scholar 

  105. Coppo R, Mazzucco G, Cagnoli L, Lupo A, Schena FP (1997) Long-term prognosis of Henoch-Schönlein nephritis in adults and children. Italian Group of Renal Immunopathology Collaborative Study on Henoch-Schönlein purpura. Nephrol Dial Transplant 12:2277–2283

    CAS  PubMed  Google Scholar 

  106. Scharer K, Krmar R, Querfeld U, Ruder H, Waldherr R, Schaefer F (1999) Clinical outcome of Schönlein-Henoch purpura nephritis in children. Pediatr Nephrol 13:816–823

    CAS  PubMed  Google Scholar 

  107. Butani L, Morgenstern BZ (2007) Long-term outcome in children after Henoch-Schönlein purpura nephritis. Clin Pediatr (Phila) 46:505–511

    Google Scholar 

  108. Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L, Locatelli F, Cagnoli L (2006) Predictors of outcome in Henoch-Schönlein nephritis in children and adults. Am J Kidney Dis 47:993–1003

    PubMed  Google Scholar 

  109. Edstrom Halling S, Soderberg MP, Berg UB (2010) Predictors of outcome in Henoch-Schönlein nephritis. Pediatr Nephrol 25:1101–1108

    PubMed  Google Scholar 

  110. Assadi F (2009) Childhood Henoch-Schonlein nephritis: a multivariate analysis of clinical features and renal morphology at disease onset. Iran J Kidney Dis 3:17–21

    PubMed  Google Scholar 

  111. Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, D'Agati V, D'Amico G, Emancipator S, Emma F, Ferrario F, Fervenza FC, Florquin S, Fogo A, Geddes CC, Groene HJ, Haas M, Herzenberg AM, Hill PA, Hogg RJ, Hsu SI, Jennette JC, Joh K, Julian BA, Kawamura T, Lai FM, Leung CB, Li LS, Li PK, Liu ZH, Mackinnon B, Mezzano S, Schena FP, Tomino Y, Walker PD, Wang H, Weening JJ, Yoshikawa N, Zhang H (2009) The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76:534–545

    PubMed  Google Scholar 

  112. Niaudet P, Habib R (1998) Methylprednisolone pulse therapy in the treatment of severe forms of Schönlein-Henoch purpura nephritis. Pediatr Nephrol 12:238–243

    CAS  PubMed  Google Scholar 

  113. Hennies I, Gimpel C, Gellermann J, Moller K, Mayer B, Dittrich K, Buscher AK, Hansen M, Aulbert W, Wuhl E, Nissel R, Schalk G, Weber LT, Pohl M, Wygoda S, Beetz R, Klaus G, Fehrenbach H, Konig S, Staude H, Beringer O, Bald M, Walden U, von Schnakenburg C, Bertram G, Wallot M, Haffner K, Wiech T, Hoyer PF, Pohl M (2018) Presentation of pediatric Henoch-Schönlein purpura nephritis changes with age and renal histology depends on biopsy timing. Pediatr Nephrol 33:277–286

    PubMed  Google Scholar 

  114. Szeto CC, Choi PC, To KF, Li PK, Hui J, Chow KM, Leung CB, Lui SF, Mac-Moune Lai F (2001) Grading of acute and chronic renal lesions in Henoch-Schönlein purpura. Mod Pathol 14:635–640

    CAS  PubMed  Google Scholar 

  115. Trimarchi H, Barratt J, Cattran DC, Cook HT, Coppo R, Haas M, Liu ZH, Roberts IS, Yuzawa Y, Zhang H, Feehally J (2017) Oxford classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int 91:1014–1021

    PubMed  Google Scholar 

  116. Davin JC, Coppo R (2013) Pitfalls in recommending evidence-based guidelines for a protean disease like Henoch-Schönlein purpura nephritis. Pediatr Nephrol 28:1897–1903

    PubMed  Google Scholar 

  117. Xu K, Zhang L, Ding J, Wang S, Su B, Xiao H, Wang F, Zhong X, Li Y (2018) Value of the Oxford classification of IgA nephropathy in children with Henoch-Schönlein purpura nephritis. J Nephrol 31:279–286

    PubMed  Google Scholar 

  118. Cakici EK, Gur G, Yazilitas F, Eroglu FK, Gungor T, Arda N, Orhan D, Ozalp Ates FS, Bulbul M (2019) A retrospective analysis of children with Henoch-Schönlein purpura and re-evaluation of renal pathologies using Oxford classification. Clin Exp Nephrol 23:939–947

    CAS  PubMed  Google Scholar 

  119. Jimenez A, Chen A, Lin JJ, South AM (2019) Does MEST-C score predict outcomes in pediatric Henoch-Schönlein purpura nephritis? Pediatr Nephrol 34:2583–2589

    PubMed  PubMed Central  Google Scholar 

  120. Koskela M, Ylinen E, Autio-Harmainen H, Tokola H, Heikkila P, Lohi J, Jalanko H, Nuutinen M, Jahnukainen T (2020) Prediction of renal outcome in Henoch-Schönlein nephritis based on biopsy findings. Pediatr Nephrol 35:659–668

    PubMed  Google Scholar 

  121. Wyatt RJ, Hogg RJ (2001) Evidence-based assessment of treatment options for children with IgA nephropathies. Pediatr Nephrol 16:156–167

    CAS  PubMed  Google Scholar 

  122. Ozen S, Marks SD, Brogan P, Groot N, de Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Pilkington C, Ravelli A, van Royen A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW (2019) European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative. Rheumatology (Oxford) 58:1607–1616

    CAS  Google Scholar 

  123. Radhakrishnan J, Cattran DC (2012) The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient. Kidney Int 82:840–856

    PubMed  Google Scholar 

  124. Crayne CB, Eloseily E, Mannion ML, Azerf SP, Weiser P, Beukelman T, Stoll ML, Feig DI, Prescott Atkinson T, Cron RQ (2018) Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature. Pediatr Rheumatol 16:71

    Google Scholar 

  125. Fenoglio R, Naretto C, Basolo B, Quattrocchio G, Ferro M, Mesiano P, Beltrame G, Roccatello D (2017) Rituximab therapy for IgA-vasculitis with nephritis: a case series and review of the literature. Immunol Res 65:186–192

    CAS  PubMed  Google Scholar 

  126. Lundberg S, Westergren E, Smolander J, Bruchfeld A (2017) B cell-depleting therapy with rituximab or ofatumumab in immunoglobulin A nephropathy or vasculitis with nephritis. Clin Kidney J 10:20–26

    PubMed  Google Scholar 

  127. Maritati F, Fenoglio R, Pillebout E, Emmi G, Urban ML, Rocco R, Nicastro M, Incerti M, Goldoni M, Trivioli G, Silvestri E, Mohammad AJ, Jayne D, Eriksson P, Segelmark M, Novikov P, Harris H, Roccatello D, Vaglio A (2018) Brief report: Rituximab for the treatment of adult-onset IgA vasculitis (Henoch-Schönlein). Arthritis Rheumatol 70:109–114

    CAS  PubMed  Google Scholar 

  128. Lafayette RA, Canetta PA, Rovin BH, Appel GB, Novak J, Nath KA, Sethi S, Tumlin JA, Mehta K, Hogan M, Erickson S, Julian BA, Leung N, Enders FT, Brown R, Knoppova B, Hall S, Fervenza FC (2017) A randomized, controlled trial of rituximab in IgA nephropathy with proteinuria and renal dysfunction. J Am Soc Nephrol 28:1306–1313

    CAS  PubMed  Google Scholar 

  129. Van de Perre E, Smith RM, Bardsley V, Crawley C, Willcocks LC, Jayne DR (2016) Successful outcome using bortezomib in adult refractory IgA vasculitis: a case report. Rheumatology (Oxford) 55:2089–2091

    Google Scholar 

  130. Chartapisak W, Opastiraku S, Willis NS, Craig JC, Hodson EM (2009) Prevention and treatment of renal disease in Henoch-Schönlein purpura: a systematic review. Arch Dis Child 94:132–137

    CAS  PubMed  Google Scholar 

  131. Szemenyei C, Hahn D (2015) Prevention of nephritis in Henoch-Schönlein purpura. J Paediatr Child Health 51:236–239

    PubMed  Google Scholar 

  132. Dudley J, Smith G, Llewelyn-Edwards A, Bayliss K, Pike K, Tizard J (2013) Randomised, double-blind, placebo-controlled trial to determine whether steroids reduce the incidence and severity of nephropathy in Henoch-Schönlein Purpura (HSP). Arch Dis Child 98:756–763

    PubMed  Google Scholar 

  133. Kim MJ, Schaub S, Molyneux K, Koller MT, Stampf S, Barratt J (2016) Effect of immunosuppressive drugs on the changes of serum galactose-deficient IgA1 in patients with IgA nephropathy. PLoS One 11:e0166830

    PubMed  PubMed Central  Google Scholar 

  134. Delbet JD, Hogan J, Aoun B, Stoica I, Salomon R, Decramer S, Brocheriou I, Deschenes G, Ulinski T (2017) Clinical outcomes in children with Henoch-Schönlein purpura nephritis without crescents. Pediatr Nephrol 32:1193–1199

    PubMed  Google Scholar 

  135. Berthelot L, Jamin A, Viglietti D, Chemouny JM, Ayari H, Pierre M, Housset P, Sauvaget V, Hurtado-Nedelec M, Vrtovsnik F, Daugas E, Group HS, Monteiro RC, Pillebout E (2018) Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort. Nephrol Dial Transplant 33:1579–1590

    CAS  PubMed  Google Scholar 

  136. Yasutake J, Suzuki Y, Suzuki H, Hiura N, Yanagawa H, Makita Y, Kaneko E, Tomino Y (2015) Novel lectin-independent approach to detect galactose-deficient IgA1 in IgA nephropathy. Nephrol Dial Transplant 30:1315–1321

    CAS  PubMed  PubMed Central  Google Scholar 

  137. Wada Y, Matsumoto K, Suzuki T, Saito T, Kanazawa N, Tachibana S, Iseri K, Sugiyama M, Iyoda M, Shibata T (2018) Clinical significance of serum and mesangial galactose-deficient IgA1 in patients with IgA nephropathy. PLoS One 13:e0206865

    PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors thank Bruce A. Julian for the critical reading of the manuscript.

Funding

This study was supported in part by NIH grants DK078244, DK082753, DK116690, and DK105124 and a gift from the IGA Nephropathy Foundation of America.

Author information

Author notes

  1. M. Colleen Hastings and Dana V. Rizk contributed equally to this work.

Authors and Affiliations

  1. Division of Pediatric Nephrology and Hypertension, Department of Pediatrics, University of Tennessee Health Science Center, Memphis, TN, USA

    M. Colleen Hastings, Rima S. Zahr & Robert J. Wyatt

  2. Division of Nephrology, Department of Medicine, University of Tennessee Health Science Center, Memphis, TN, USA

    M. Colleen Hastings

  3. Children’s Foundation Research Institute at the Le Bonheur Children’s Hospital, Memphis, TN, USA

    M. Colleen Hastings, Rima S. Zahr & Robert J. Wyatt

  4. Department of Medicine, Division of Nephrology, University of Alabama at Birmingham, Birmingham, AL, USA

    Dana V. Rizk

  5. Division of Nephrology, Department of Medicine, College of Physicians & Surgeons, Columbia University, New York, NY, USA

    Krzysztof Kiryluk

  6. Division of Pediatric Nephrology, Department of Pediatrics, University of Utah, Salt Lake City, UT, USA

    Raoul Nelson

  7. Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA

    Jan Novak

Authors
  1. M. Colleen Hastings
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dana V. Rizk
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Krzysztof Kiryluk
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Raoul Nelson
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rima S. Zahr
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jan Novak
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Robert J. Wyatt
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert J. Wyatt.

Ethics declarations

Conflict of interest

DVR and JN are co-founders and co-owners of and consultants for Reliant Glycosciences, LLC. JN and RJW are co-inventors on US patent application 14/318,082 (assigned to UAB Research Foundation).

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hastings, M.C., Rizk, D.V., Kiryluk, K. et al. IgA vasculitis with nephritis: update of pathogenesis with clinical implications. Pediatr Nephrol 37, 719–733 (2022). https://doi.org/10.1007/s00467-021-04950-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-021-04950-y

Keywords

Search

Navigation